Yes — in most cases an underactive thyroid (hypothyroidism) does not stop you taking Mounjaro (tirzepatide), and taking levothyroxine is not a barrier either. What genuinely rules people out is a personal or family history of medullary thyroid cancer, the genetic condition MEN2, or certain other specific conditions — not a simple underactive thyroid. Whether it is suitable for you is still decided by a prescriber after a free online consultation.
Many people wrongly self-exclude here. The word "thyroid" appears in the safety information for these medicines, and it is easy to assume that any thyroid problem is a red flag. That is not the case, so it is worth understanding exactly where the line is drawn.
Why an underactive thyroid is not a contraindication
Hypothyroidism means your thyroid gland does not produce enough thyroid hormone, which can slow metabolism and contribute to weight gain and fatigue. It is very common in the UK and is usually managed well with daily levothyroxine.
Mounjaro works in a completely different part of the body from the thyroid. It activates two gut-hormone receptors — GLP-1 and GIP — which reduce appetite and slow how quickly your stomach empties, so you feel fuller sooner and for longer. It does not act on thyroid hormone levels, and having an underactive thyroid does not change how it works on appetite.
Because of this, a stable, well-managed underactive thyroid is not on the list of conditions that prevent treatment.
What thyroid history actually rules Mounjaro out
The thyroid-related reasons a prescriber cannot offer Mounjaro (or the other GLP-1 medicines) are specific:
- Personal or family history of medullary thyroid carcinoma (MTC) — a rare type of thyroid cancer.
- Multiple Endocrine Neoplasia type 2 (MEN2) — a genetic syndrome linked to MTC.
These come from animal studies and are a precaution built into the licence for the whole GLP-1 medicine class. If you have had thyroid surgery for one of these reasons, or your family carries MEN2, that history is important to disclose.
An underactive thyroid, Hashimoto's thyroiditis, a previously treated overactive thyroid, or a thyroid nodule that is not cancerous are different matters entirely and do not automatically exclude you. Always tell the prescriber your full thyroid history so they can make the right decision.
Taking Mounjaro alongside levothyroxine
Levothyroxine and Mounjaro can generally be taken together. There is no direct interaction that makes them unsafe as a pair.
There is, however, one practical point worth knowing. Mounjaro slows down stomach emptying, and levothyroxine is a medicine whose absorption can be sensitive to timing and to what is in your stomach.
- Keep taking your levothyroxine exactly as directed — usually first thing in the morning on an empty stomach, with water, and waiting before eating or other medicines.
- If your appetite, eating pattern or weight changes noticeably on Mounjaro, your GP or endocrinologist may want to check your thyroid function (a TSH blood test) and adjust your levothyroxine dose if needed.
- Do not change your thyroid medicine yourself — any adjustment should be guided by the clinician who manages it.
Weight change itself can slightly alter how much thyroid hormone your body needs, so routine monitoring after any significant weight loss is sensible regardless of which medicine caused it.
The full eligibility picture
Thyroid history is only one part of the assessment. To be considered for Mounjaro in the UK you generally need to be:
- Aged 18 or over;
- A BMI of 30 or above (obesity), or
- A BMI of 27–30 with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea.
Mounjaro is not suitable if you are pregnant, planning pregnancy or breastfeeding; have type 1 diabetes; have a history of pancreatitis; have severe gastrointestinal disease; have an active eating disorder; have severe liver or kidney impairment; or are allergic to the active ingredient. The medullary thyroid cancer and MEN2 history above sits within this list — a simple underactive thyroid does not.
How Mounjaro is prescribed and taken
Mounjaro is a weekly self-injection. Treatment starts at a low 2.5mg dose and is increased gradually — 5mg, 7.5mg, 10mg, 12.5mg — up to a maximum licensed dose of 15mg, with prescriber review at each step. This slow build-up helps limit side effects.
In the SURMOUNT-1 trial, participants on the 15mg dose lost on average 22.5% of body weight over 72 weeks, alongside lifestyle support. Individual results vary; not everyone reaches this.
Monthly prices at The Weight Clinic are: 2.5mg £160, 5mg £185, 7.5mg £240, 10mg £260, 12.5mg £275 and 15mg £295. The consultation is free — you only pay if treatment is prescribed and you choose to go ahead.
Common side effects
The most common side effects (affecting more than 1 in 10 people) are nausea, diarrhoea, constipation, vomiting, decreased appetite and fatigue. These are usually mildest at the lower doses and often settle as your body adjusts.
Rare but serious risks include severe allergic reaction, acute pancreatitis, severe hypoglycaemia (particularly if combined with certain diabetes medicines), severe gastrointestinal disease and worsening of diabetic retinopathy.
Fatigue is worth flagging to your prescriber, because tiredness can also be a sign of an under-treated thyroid — so it helps them know your thyroid is being monitored. You can report any suspected side effect through the MHRA Yellow Card scheme at https://yellowcard.mhra.gov.uk/.
Other options if you are exploring treatment
Mounjaro is one of several licensed weight-management medicines. The same thyroid rules apply across the GLP-1 class, so an underactive thyroid does not single out any one of them.
- Wegovy injection (semaglutide) — a once-weekly GLP-1 injection.
- Wegovy Tablet (oral semaglutide) — a once-daily tablet taken on an empty stomach.
- See all treatments for a fuller overview, or compare the weight-loss injections.
The right choice depends on your health history, preferences and what the prescriber judges to be clinically appropriate.
The bottom line
An underactive thyroid, and taking levothyroxine, will not by themselves stop you being prescribed Mounjaro in the UK. The thyroid conditions that do rule it out are medullary thyroid cancer and MEN2. Be open about your full thyroid history in the consultation so the prescriber can assess you accurately.
If you would like to find out where you stand, you can complete a free online consultation. A GPhC-registered prescriber reviews your answers and decides whether treatment is suitable and safe for you — a prescription is only issued if it is clinically appropriate. You can read more about The Weight Clinic or get in touch with any questions.
This article is for information only and is not a substitute for personalised medical advice. Weight-loss medicines are prescription-only, are not suitable for everyone, and are prescribed only after a clinical consultation with a GPhC-registered prescriber. Individual results vary. Always speak to a UK-registered pharmacist or doctor before starting or changing any prescription medication.
